PMC:7600245 / 17581-17712
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T65","span":{"begin":92,"end":103},"obj":"Disease"},{"id":"T66","span":{"begin":92,"end":101},"obj":"Disease"},{"id":"T67","span":{"begin":116,"end":125},"obj":"Disease"}],"attributes":[{"id":"A65","pred":"mondo_id","subj":"T65","obj":"http://purl.obolibrary.org/obo/MONDO_0005344"},{"id":"A66","pred":"mondo_id","subj":"T66","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"},{"id":"A67","pred":"mondo_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"It a thymidine nucleoside analog (Figure 3) that was approved in Korea for the treatment of hepatitis B virus (HBV) infection [60]."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T159","span":{"begin":3,"end":4},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T160","span":{"begin":102,"end":103},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T161","span":{"begin":104,"end":109},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"It a thymidine nucleoside analog (Figure 3) that was approved in Korea for the treatment of hepatitis B virus (HBV) infection [60]."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T186","span":{"begin":5,"end":14},"obj":"Chemical"},{"id":"T187","span":{"begin":15,"end":25},"obj":"Chemical"}],"attributes":[{"id":"A186","pred":"chebi_id","subj":"T186","obj":"http://purl.obolibrary.org/obo/CHEBI_17748"},{"id":"A187","pred":"chebi_id","subj":"T187","obj":"http://purl.obolibrary.org/obo/CHEBI_33838"}],"text":"It a thymidine nucleoside analog (Figure 3) that was approved in Korea for the treatment of hepatitis B virus (HBV) infection [60]."}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T9","span":{"begin":92,"end":101},"obj":"Phenotype"}],"attributes":[{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0012115"}],"text":"It a thymidine nucleoside analog (Figure 3) that was approved in Korea for the treatment of hepatitis B virus (HBV) infection [60]."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T131","span":{"begin":0,"end":131},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"It a thymidine nucleoside analog (Figure 3) that was approved in Korea for the treatment of hepatitis B virus (HBV) infection [60]."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"451","span":{"begin":5,"end":25},"obj":"Chemical"},{"id":"455","span":{"begin":92,"end":125},"obj":"Disease"}],"attributes":[{"id":"A455","pred":"tao:has_database_id","subj":"455","obj":"MESH:D006509"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"It a thymidine nucleoside analog (Figure 3) that was approved in Korea for the treatment of hepatitis B virus (HBV) infection [60]."}